Pediatric Normative Markerless Movement Analysis

NCT06249880 | Recruiting

• 1 other identifier: #2023/11/2
• Study Type: observational
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

The objective of this project is to collect baseline data from a normative population of 20 children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab.

Conditions

Pediatric ALL; Adolescent

Keywords

Motion Analysis; Kinetics; Kinematics

Outcome Measures

Primary Outcomes (1)

• Observation-based movement analyses

  The purpose of this normative data collection study is to collect baseline data from a normative population of children/adolescents using force plates and 3D markerless motion capture. Together these are used to calculate a normative range of body position and joint angles (kinematics), as well as joint loads and ground reaction forces (kinetics) during prescribed activities.

  Baseline

Study Arms (1)

Normative

40 neurotypical pediatric subjects

Other: Observation

Interventions

Observation OTHER

This project seeks to recruit 20 male and 20 female typically developing individuals, between the ages of 3 and 25 years of age. Non-invasive measurements of movement patterns (motion analysis and force plate data) will be collected during bipedal gait.

Normative

Eligibility Criteria

• Age: 3 Years - 25 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Subjects will be recruited from the regional community, including convenience sample of children. Subjects will be recruited by word of mouth, posted flyers, and advertised through the RML website and MB social media.

You may qualify if:

• Ambulate independently and without the use of assistive devices or orthoses.
• Willing and interested in participating.

You may not qualify if:

• Neuromuscular disorders such as cerebral palsy, muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, peripheral neuropathy, or other generalized muscle and/or nerve issues.
• Evidence of developmental delays, muscle weakness, decreased muscle tone, joint stiffness, muscle or bone deformity.
• Currently using or has a history of using assistive technology devices, bracing/orthoses, manual or powered mobility equipment.
• History of premature birth.
• Currently or has a history of taking medication or pharmaceutical treatment related to musculoskeletal side-effects/scenario/diagnosis.

Sponsors & Collaborators

• MultiCare Health System Research Institute: lead

Study Sites (1)

Mary Bridge Children's Therapy Unit - Research & Movement Lab

Puyallup, Washington, 98372, United States

RECRUITING

MeSH Terms

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

Observation

Condition Hierarchy (Ancestors)

Leukemia, Lymphoid; Leukemia; Neoplasms by Histologic Type; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases; Lymphoproliferative Disorders; Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases

Intervention Hierarchy (Ancestors)

Methods; Investigative Techniques

Study Officials

• Brenna Brandsma

  Mary Bridge Chidlren's

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Brenna Brandsma, PT, DPT, PCS

CONTACT

253-697-5268; brenna.brandsma@multicare.org

Sean Brown, PhD

CONTACT

253-697-5402; sean.brown@multicare.org

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Physical Therapist

Study Record Dates

• First Submitted: January 24, 2024
• First Posted: February 8, 2024
• Study Start: March 1, 2024
• Primary Completion (Estimated): December 1, 2027
• Study Completion (Estimated): December 1, 2028
• Last Updated: March 9, 2026

Record last verified: 2026-03

Locations

US (1)